MR imaging of the breast

Imaging

Volumn 9, Issue 4, 1997, Pages 187-200

  Turnbull, Lindsay W ^a  

^a HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST; BREAST CANCER; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SCREENING TEST; TUMOR RECURRENCE;

EID: 0031396337     PISSN: 09656812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Feig SA. Decreased breast cancer mortality through mammographic screening: Results of clinical trials. Radiology 1988; 167: 659-665.
2. Ciatto S, Cataliott L, Distante V. Non palpable lesions detected by mammography: Review of 512 consecutive cases. Radiology 1987; 165: 92-102.
3. Heywang SH, Hahn D, Schmidt H, et al. MR imaging of the breast using Gd-DTPA. JCAT 1986; 10: 615-620.
4. Heywang SH, Wolf A, Pruss E, Hilbertz T, Eiermann W, Permanetter W. MR imaging of the breast with Gd-DTPA: Use and limitations. Radiology 1989; 171: 95-103.
5. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology 1989; 170: 681-686.
6. Gilles R, Guinebretiêre J, Lucidarme O, et al. Non palpable breast tumours: Diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 1994; 191: 625-631.
7. Greenstein Orel S, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: Effect of MR imaging and MR-guided biopsy. Radiology 1995; 196: 115-122.
8. Oellinger H, Heins S, Sander B, et al. Gd-DTPA enhanced MR breast imaging: The most sensitive method for multicentric carcinomas of the female breast. Europ Radiol 1993; 3: 223-226.
9. Allgayer B, Lukas P, Loos W, et al. MRT der Mamma mit 2D-Spinecho-und Gradientenechosequenzen in diagnostischen Problemfällen. ROFO 1993; 158: 423-427.
10. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathological correlation. Radiology 1993; 187: 493-501.
11. Tesoro-Tess JD, Amoruso A, Turrini E, et al. Microcalcification in clinically normal breast: The value of high-field surface coil, Gd-DTPA-enhanced MR imaging. J Magn Reson Imaging 1993; 3(P): 48.
12. Fischer U, v Heyden D, Vosshenrich R, et al. Signal-verhalten maligner und benigner Läsionen in der dynamischen 2D-MRT der Mamma. Fortschritte auf den Gebiet der Roentgenshahlen 1993; 158: 287-292.
13. Heywang SH, Hilbertz T, Pruss E, et al. Dynamische kontrastmitteluntersuchungen mit FLASH bei kernspintomographie der mamma. Digitale Bilddiagn 1988; 8: 7-13.
14. Heywang-Koebrunner SH, Beck R, Lommatsch B, et al. Contrast-enhanced MR imaging of the breast: Survey of 1,200 patient examinations. Radiology 1992; 185(P): 246.
15. Heywang-Koebrunner SM, Beck R, Schmidt F, et al. Use of contrst-enhanced MR imaging of the breast for problem cases. Radiology 1993; 189(P): 105.
16. Kaiser WA, Reiser MR. MR mammography: Experience after 650 examinations. J Magn Reson Imaging 1992; 2(P): 88.
17. Kaiser WA. False-positive results in dynamic MR mammography. Magnetic Resonance imaging. Clin N Am 1994; p. 539-557.
18. Stack JP, Redmond OM, Cobb MB, et al. Breast disease: tissue characterisation with Gd-DTPA enhancement profiles. Radiology 1990; 174: 491-494.
19. Gilles R, Guinebretiere JM, Shapeero LG, et al. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients. Radiology 1993; 188: 473-478.
20. Gilles R, Guinebretiere JM, Lucidarme O, et al. Nonpalpable breast tumours: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 1994; 191: 625-631.
21. Turkat TJ, Klein BD, Polan RL, et al. Dynamic MR mammography: a technique for potentially reducing the biopsy rate for benign breast disease. J Magn Reson Imaging 1994; 4: 563-568.
22. Gribbestad IS, Nilsen G, Fjosne HE, et al. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography. J Magn Reson Imaging 1994; 4: 477-480.
23. Weinreb JC, Newstead G. MR imaging of the breast. Radiology 1995; 196: 593-610.
24. Kelcz F, Santyr GE, Cron GO, Mongin SJ. Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic, gadolinium-enhanced MRI. J Magn Reson Imaging 1996; 6: 743-752.
25. Morgan PH, Mercer LP, Flodin NW. General model for nutritional responses of higher organisms. Proc Natl Acad Sci USA 1995; 72: 4327-4331.
26. Boetes C, Barentsz JO, Mus RD, van der Sluis RF, et al. MR characterisation of suspicious breast lesions with the gadolinium enhanced Turbo FLASH subtraction technique. Radiology 1994; 193: 777-781.
27. Hulka CA, Smith BL, Sgroi DC, et al. Benign and malignant breast lesions: differentiation with echo-planar MR imaging. Radiology 1995; 197: 33-38.
28. Hulka CA, Edminster WB, Smith BL, Tan L, Sgroi DC, Campbell T, Kopans DB, Weisskoff RM. Dynamic echoplanar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumour angiogenesis. Radiology 1997; 205: 837-842.
29. Su MY, Jao JC, Nalcioglu O. Measurement of vascular volume fraction and blood-tissue permeability constancy with pharmacokinetic model: studies in rat muscle tumours with dynamic Gd-DTPA enhanced MRI. Magn Reson Med 1994; 32: 714.
30. Buckley DL, Kerslake RW, Blackband SJ, Horsman A. Quantitative analysis of multi-slice Gd-DTPA enhanced dynamic MR images using an automated simplex minimisation procedure. Magn Reson Med 1994; 32: 646-651.
31. Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumours using a permeability model. Magn Reson Med 1995; 33: 564-568.
32. Hoffmann U, Brix G, Knopp MV, et al. Pharmacokinetic mapping of the breast: A new method for dynamic MR mammography. Magn Reson Med 1995; 33: 506-514.
33. Brix G, Semmler W, Port R, et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991; 15: 621-628.
34. Knopp MV, Junkermann HJ, Hoffmann U, Sinn P, Himmelhan N, Zabel S, Juschka U, Hess T, Essig M, Brix G, van Kaick G. Fast dynamic MR imaging for characterisation of breast lesions. Experiences of functional MR mammography. 4th Scientific Meeting of the ISMRM, New York, USA, 1996, p. 353.
35. Weinmann HJ, Laniado M, Mutzel W. Pharmacokinetics of Gd-DTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR. 1984; 16: 167-172.
36. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson. Med. 1991; 17: 357-367.
37. Yen Y-F, Herfkens RJ, Birdwell R, Daniel BL, Sawyer AM, Glover GH. Temporal consideration in dynamic breast MRI with spiral sequence. In: Proc 5th Int Soc Magnetic Resonance in Medicine, 1997, No 314.
38. Hess T, Knopp MV, Brix G, et al. Pharmakokinetische Analyse der Gd-DTPA Anreicherung in der MRT beim Mammakarzinom. Fortschr Röntgenstr. 1994; 160: 518.
39. Knowles AJ, Issa B, Burton S, Liney GP, Gibbs P, Turnbull LW. Classification of benign and malignant disease by neural network analysis of dynamic imaging. Proc Radiol 1998, in press.
40. Frouge C, Guinebretiêre J, Contesso G, et al. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumour angiogenesis. Investigative Radiology 1994; 29(12): 1043-1049.
41. Fobben ES, Rubin CZ, Kalisher L, Dembner AG, Seltzer MH, Santoro EJ. Breast MR imaging with commercially available techniques: Radiologic-pathologic correlation. Radiology 1995; 196: 143-152.
42. Greenstein Orel S, Schnall MD, LiVolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994; 190: 485-493.
43. Hochman MG, Orel SG, Powell CM, Schnall MD, Reynolds CA, White LN. Fibroadenomas: MR imaging appearances with radiologic-pathologic correlation. Radiology 1997; 204: 123-129.
44. Sherif H, Mahfoud AE, Oellinger H, Hadijuana J, Blohmer JU, Taupitz M, Roland F, Hamm B. Peripheral wash-out sign on contrast-enhanced images of the breast. Radiology 1997; 205: 209-213.
45. Cecil KM, McDermott J, Schnall MD, Bolinger L. Breast imaging at 4.OT results in improved visualisation of lesion architecture. Proc 4th Meet ISMRM, New York, USA; 1996, p. 349.
46. Kuhl CK, Bieling H, Gieseke J, Ebel T, Mielcarek P, Far F, Folkers P, Elevelt A, Schild HH. Breast neoplasms: T2* susceptibility-contrast first-pass perfusion MR imaging. Radiology 1997; 202: 87-95.
47. Lucas-Quesada FA, Sinha U, DeBruhl ND, Bassett LW, Sinha S. Feasability study of diffusion weighted echo-planar imaging of the breast. In: Proc 5th Int Soc Magnetic Resonance in Medicine, 1997, No 313.
48. Maier CF, Paran Y, Bendel P, Rutt BK, Degani H. Quantitative diffusion imaging in implanted human breast tumours. Magn Reson Med 1997; 37: 576-581.
49. Schreiber W, Hess T, Brix G, Knopp MV, Lorenz WJ. Gd-DTPA enhanced imaging of the breast: MT FLASH compared with FLASH. Proc 2nd Meet ISMRM, San Francisco, USA, 1994, p. 1457.
50. Fowlkers JB, Emelianov SY, Pipe JG, Skovoroda AR, Carso PL, Adler RS, Saravazyan AP. Magentic resonance imaging techniques for detection of elastcity variation. Med Phys 1995; 22: 1771-1778.
51. Issa B, Buckley DL, Mussurakis S, Horsman A. Statistical analysis of contrast-enhanced breast images. 5th Scientific Meeting of ISMRM, Vancouver, Canada, 1997, p. 1049.
52. Sinha S, Lucas-Quesada FA, DeBuhl ND, Sayre J, Farria D, Gorczya DP, Bassett LW. Multifeature analysis of Gd-enhanced MR images of breast lesions. J Magn Reson Imaging 1997; 7: 1016-1026.
53. Davies PL, Staiger MJ, Harris KB, Ganott MA, Klementaviciene J, McCarthy KS, Tobon H. Breast cancer measurements with magnetic resonance imaging, ultrasonography and mammography. Breast Cancer Research and Treatment 1996; 37: 1-9.
54. Ando Y, Fukatsu H, Ishigaki T, Endo T, Mikazaki M. Evaluation of breast cancer vascularity using MR mammography. Proc 5th Int Soc Magnetic Resonance in Medicine, Vancouver, April 1997, Abstract No. 1045.
55. Balen FG, Hall-Craggs MA, Mumtaz H, Wilkinson I, Scheidau A. MRI of invasive lobular carcinoma of the breast. Proc Radiol 1997, Birmingham, May 1997, p. 51.
56. Deutch BM, Merchant TE, Scwartz LH, Powell CM, Liberman I, Dershaw DD. Local staging of breast cancer by using MR imaging (abstr.) Radiology 1993; 189(P): 301.
57. Fischer U, Vosshenrich R, Kopka M, von Heyden D, Oestmann JW, Grabbe EH. Preoperative MR mammography in patients with breast cancer: impact on therapy (abstr.) Radiology 1994; 193(P): 121.
58. Whitney WS, Herfkens RJ, Silverman J, Ikeda D, Brumbaugh J, Jeffreys S. Gadolinium-enhanced spectral-spatial MR imaging for evaluation of breast carcinoma (abstr.) Radiology 1993; 189(P): 136.
59. Krämer S, Döinghaus K, Schulz-Wendtland R, Lang N, Bautz W. The role of MR-mammography in the diagnosis of multicentricity in breast cancer. Proc Radiol 1997, Birmingham, May 1997, p. 51.
60. Guidi AJ, Fischer L, Harris JR, Schnitt SJ. Microvessel density and distribution in ductal carcinoma in situ in the breast. J Natl Cancer Inst 1994; 86: 614-619.
61. Gilles R, Zafrani B, Guinebretiere JM, et al. Ductal carcinoma in situ: MR imaging-histopathological correlation. Radiology 1995; 190: 415-419.
62. Mendonca MH, Schnall MD, Orel S, Reynolds C. High resolution MRI of ductal carcinoma in situ. ISMRM, p. 347.
63. Greenstein Orel S, Mendonca MH, Reynolds C, Schnall MD, Solin LJ, Sullivan DC. MR imaging of ductal carcinoma in situ. Radiology 1997; 202: 413-420.
64. Tilanus Linthorst MMA, Obdeijn AIM, Bontenbal M, Oudkerk M. MRI in patients with axillary metastases of occult breast carcinoma. Breast Cancer Research and Treatment 1997; 44: 179-182.
65. Bird R, Wallace T, Yankaskas B. Analysis of cancers missed at screening mammography. Radiology 1992; 184: 613-617.
66. Tabar L, Fagerberg G, Duffy SW, Day NE, Gaad A, Grontoft O. Update of the Swedish two-country program of mammographic screening for breast cancer. Radiol Clin North Am 1992; 30: 187-210.
67. Peeters PHM, Verbeek ALM, Hendriks J, Van Bon MJH. Screening of breast cancer in Nijmegen: report of 6 screening rounds, 1975-1986. Int J Cancer 1989; 43: 226-230.
68. Kuhl CK, Bieling HB, Gieseke K, Kreft BP, Sommer T, Lutterbey G, Schild HH. Health premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: Normal contrast medium enhancement and cyclic-phase dependency. Radiology 1997; 203: 137-144.
69. Muller-Schimpfle M, Ohmenhäuser K, Stoll P, Dietz K, Claussenn CD. Menstrual cycle and age: Influence of parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 1997; 203: 145-149.
70. National Multi-centre study of MRI screening in women at genetic risk of breast cancer. Lancet, 1997, July 5th (http://www.thelancet.com).
71. Montague ED, Gutierrez AE, Barker JL, et al. Conservative surgery and irradiation for the treatment of favorable breast cancer. Cancer 1979; 43: 1058.
72. Fisher B, Bauer M, Margolese R, et al. Five year results of a randomised clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985; 312: 665-673.
73. Veronesi U, Banfi A, Salvadori B, et al. Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomised trial. Eur J Cancer 1990; 26: 668.
74. Harris JR, Recht A, Amalric R, et al. Time course and prognosis of local recurrence following primary radiation therapy for early breast cancer. J Clin Oncol 1984; 2(1): 37-41.
75. Chu F, Lin F, Kim J, Huh SH, Garmatis CJ. Locally recurrent carcinoma of the breast: Results of radiation therapy. Cancer 1976; 37: 2677-2681.
76. Libshitz HI, Montague ED, Paulus DD. Calcifications in the therapeutically irradiated breast. Am J Roentgenol 1977; 128: 1021.
77. Mendelson EB. Imaging the post-surgical breast. Semin in Ultrasound CT MR 1989; 10: 154.
78. Stomper PC, Recht A, Berenberg AL, Jochelson MS, Harris JR. Mammographic detection of recurrent cancer in the irradiated breast. Am J Roentgenol 1987; 148: 39-43.
79. Hassell, et al. 1990; Dershaw DD, McCormick B, Cox L, Osborne MP. Differentiation of benign and malignant local tumour recurrence after lumpectomy. Am J Roentgenol 1990; 155: 35-38.
80. Dershaw DD, McCormick B, Cox L, Osborne MP. Differentiation of benign and malignant locval tumour recurrence after lumpectomy. Am J Roentgenol 1990; 155: 35-38.
81. Heywang SH, Hilbertz T, Beck R, Bauer WM, Eiermann W, Permanetter W. Gd-DTPA enhanced MR imaging of the breast in patients with postoperative scarring and silicon implants. J Comput Assist Tomogr 1990; 14: 348-356.
82. Lewis-Jones HG, Whitehouse GH, Leinster SJ. The role of magnetic resonance imaging in the assessment of local recurrent breast carcinoma. Clin Radiol 1991; 43: 197-204.
83. Hickman PF, Moore NR, Shepstone BJ. The indeterminate breast mass: Assessment with contrast-enhanced magnetic resonance imaging. Br J Radiol 1994; 67: 14.
84. Kerslake RW, Fox JN, Carleton PJ, et al. Dynamic contrast-enhanced and fat suppressed magnetic resonance imaging in suspected recurrent carcinoma of the breast: preliminary experience. Br J Radiol 1994; 67: 1158-1168.
85. Mussurakis S, Buckley DL, Bowsley SJ, Carleton PJ, Fox JN, Turnbull LW, Horsman A. Dynamic contrast-enhanced MR imaging of the breast combined with pharmacokinetic analysis of Gd-DTPA uptake in the diagnosis of recurrence of early-stage breast carcinoma. Invest Radiol, 1995; 30: 650-662.
86. Murray AD, Redpath TW, Needham G, Gilbert FJ, Brookes JA, Eremin O. Dynamic magnetic resonance mammography of both breasts following local excision and radiotherapy for breast carcinoma. Br J Radiol 1996; 69: 594-600.
87. Buckley DL, Mussurakis S, Horsman A. Effect of temporal resolution on the diagnostic efficacy of contrast-enhanced MRI in the conservatively treated breast. J Comput Assist Tomogr 1998; 22: 47-51.
88. Heywang-Koebrunner SH, Schlegel A, Beck R, et al. Contrast-enhanced MRI of the breast after limited surgery and radiation therapy. J Comput Assist Tomogr 1993; 17: 891-900.
89. Soderstrom CE, Harms SE, Farrell RS, Pruneda JM, Flamig DP. Detection with MR imaging of residual tumour in the breast soon after surgery. AmJ Roentgenol 1997; 168: 485-488.